XML 93 R16.htm IDEA: XBRL DOCUMENT v3.19.2
Note 10 - Share-based Compensation
12 Months Ended
Jun. 30, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
10.
Share-Based Compensation
 
 
The Company currently provides share-based compensation under
one
equity incentive plan approved by the Board of Directors and the shareholders:
 
 
2017
Equity Incentive Plan (
2017
Incentive Plan).
 
The
2006
Director Plan allowed the Board of Directors to grant options to purchase up to
1,000,000
shares of common stock to directors of the Company. The plan expired on
August 16, 2016.
 
Options granted prior to fiscal
2017
were made pursuant to plans that have expired or were terminated.
 
The Company’s shareholders approved the
2017
Incentive Plan (
“2017
Plan”) in
June 2017.
The
2017
Plan allows the Board of Directors to grant up to
4,000,000
shares of common stock to directors, officers, employees and consultants in a combination of equity incentive forms including incentive stock options (ISO), non-qualified stock options (NQSO), stock appreciation right (SAR) or restricted shares (RSU) of common stock. Options granted under all of the Plans have a
ten
year maximum term, an exercise price equal to at least the fair market value of the Company’s common stock (based on the trading price on the NYSE American) on the date of the grant, and with varying vesting periods as determined by the Board.
 
The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options which have
no
vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including the expected stock price volatility. The Company uses the Black-Scholes option valuation model because management believes the model is appropriate for the Company. However, management understands that because changes in the subjective input assumptions can materially affect the fair value estimate, this valuation model does
not
necessarily provide a reliable single measure of the fair value of its stock options. The risk-free interest rate is based on the U.S. treasury security rate with an equivalent term in effect as of the date of grant. The expected option lives and volatility assumptions are based on historical data of the Company.
 
The weighted average fair value of stock option awards granted and the key assumptions used in the Black-Scholes valuation model to calculate the fair value are as follows:
 
     
For the Year Ended June 30,
 
     
2019
     
2018
   
2017
 
Weighted average fair value
   
 
$0.31
 
     
 
$0.34
 
     
 
$0.45
 
 
Options issued
   
 
1,252,500
 
     
 
1,125,000
 
     
 
2,150,000
 
 
Exercise price    
$0.37
to
$0.55
     
$0.44
to
$0.58
     
$0.55
to
$0.84
 
Expected term (in years)
   
 
5
 
     
 
5
 
     
4
to
5
 
Risk-free rate
   
1.83%
to
2.91%
     
1.83%
to
2.85%
     
1.62%
to
1.83%
 
Volatility
   
89%
-
105%
     
94% 
-
101%
     
101%
-
103%
 
 
The following table presents the share-based compensation expense (in thousands):
 
   
For the Year Ended June 30,
 
   
2019
   
2018
   
2017
 
Cost of sales
  $
38
    $
62
    $
86
 
Research and development expense
   
84
     
92
     
60
 
Sales and marketing expense
   
96
     
92
     
86
 
General and administrative expense
   
202
     
158
     
140
 
Total share-based compensation
  $
420
    $
404
    $
372
 
 
The total value of the stock options awards is expensed ratably over the vesting period of the employees receiving the awards. As of
June 30, 2019,
total unrecognized compensation cost related to stock-based options and awards was
$632,000
and the weighted-average period over which it is expected to be recognized is approximately
1.08
years.
 
A summary of stock option information within the Company’s share-based compensation plans during the fiscal years is presented below:
 
   
Options
   
 
 
 
 
 
 
 
 
 
 
 
   
Outstanding
   
Price (a)
   
Life (b)
   
Value (c)
 
Balance at June 30, 2016
   
2,925,059
    $
1.21
     
6.93
    $
263
 
Granted (d)
   
2,150,000
     
.61
     
 
     
 
 
Expired/Forfeited
   
(509,904
)
   
2.55
     
 
     
 
 
Voided
   
(1,179,164
)
   
.94
     
 
     
 
 
Exercised
   
(6,800
)
   
.26
     
 
     
 
 
Balance at June 30, 2017
   
3,379,191
    $
0.78
     
7.86
    $
151
 
Granted (d)
   
1,125,000
     
.47
     
 
     
 
 
Expired
   
(100,000
)
   
.75
     
 
     
 
 
Forfeited
   
(561,541
)
   
.77
     
 
     
 
 
Exercised
   
(82,810
)
   
.61
     
 
     
 
 
Balance at June 30, 2018
   
3,759,840
    $
0.69
     
7.75
    $
49
 
Granted (d)
   
1,252,500
     
.44
     
 
     
 
 
Expired
   
(242,000
)
   
.41
     
 
     
 
 
Forfeited
   
(68,125
)
   
.54
     
 
     
 
 
Exercised
   
(56,900
)
   
.26
     
 
     
 
 
Balance at June 30, 2019
   
4,645,315
    $
0.64
     
7.95
    $
1
 
                                 
Vested and expected to vest at June 30, 2019
   
4,645,315
    $
0.64
     
7.95
    $
1
 
                                 
Exercisable at June 30, 2019
   
2,153,645
    $
0.81
     
6.76
    $
-
 
 
(a)
Weighted average exercise price per share.
(b)
Weighted average remaining contractual life.
(c)
Aggregate intrinsic value (in thousands).
(d)
All options granted had exercise prices equal to or greater than the ending closing market price of the Company’s common stock on the grant date. The options were granted to employees and management by the Compensation Committee and had vesting periods from immediate to
five
years.
 
   
For the Year Ended June 30,
 
   
2019
   
2018
   
2017
 
Aggregate intrinsic value of options exercised (in thousands)
  $
11
    $
-
    $
3
 
 
The Company’s current policy is to issue new shares to satisfy option exercises.